WO2002039926A2 - Stent and catheter assembly and method for treating bifurcated vessels - Google Patents

Stent and catheter assembly and method for treating bifurcated vessels Download PDF

Info

Publication number
WO2002039926A2
WO2002039926A2 PCT/US2001/032470 US0132470W WO0239926A2 WO 2002039926 A2 WO2002039926 A2 WO 2002039926A2 US 0132470 W US0132470 W US 0132470W WO 0239926 A2 WO0239926 A2 WO 0239926A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
vessel
main
guide wire
catheter
Prior art date
Application number
PCT/US2001/032470
Other languages
French (fr)
Other versions
WO2002039926A3 (en
Inventor
Paul Reiss
Mary Dennehy
Original Assignee
Advanced Cardiovascular Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Cardiovascular Systems, Inc. filed Critical Advanced Cardiovascular Systems, Inc.
Priority to AU2002213349A priority Critical patent/AU2002213349A1/en
Publication of WO2002039926A2 publication Critical patent/WO2002039926A2/en
Publication of WO2002039926A3 publication Critical patent/WO2002039926A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis

Definitions

  • the invention relates to stent deployment assemblies for use at a bifurcation and, more particularly, a catheter assembly for implanting one or more stents for repairing bifurcations, the aorto-ostium, and bifurcated blood vessels that are diseased, and a method and apparatus for delivery and implantation.
  • Stents conventionally repair blood vessels that are diseased and are generally hollow and cylindrical in shape and have terminal ends that are generally perpendicular to its longitudinal axis.
  • the conventional stent is positioned at the diseased area of a vessel and, after placement, the stent provides an unobstructed pathway for blood flow.
  • the stent must overlay the entire diseased area at the bifurcation, yet not itself compromise blood flow. Therefore, the stent must, without compromising blood flow, overlay the entire circumference of the ostium to a diseased portion and extend to a point within and beyond the diseased portion. Where the stent does not overlay the entire circumference of the ostium to the diseased portion, the stent fails to completely repair the bifurcated vessel. Where the stent overlays the entire circumference of the ostium to the diseased portion, yet extends into the junction comprising the bifurcation, the diseased area is repaired, but blood flow may be compromised in other portions of the bifurcation.
  • Unapposed stent elements may promote lumen compromise during neointimalization and healing, producing restenosis and requiring further procedures. Moreover, by extending into the junction comprising the bifurcation, the stent may block access to portions of the bifurcated vessel that require performance of further interventional procedures. Similar problems are encountered when vessels are diseased at their angled origin from the aorta as in the ostium of a right coronary or a vein graft. In this circumstance, a stent overlying the entire circumference of the ostium extends back into the aorta, creating problems, including those for repeat catheter access to the vessel involved in further interventional procedures.
  • Conventional stents are designed to repair areas of blood vessels that are removed from bifurcations and, since a conventional stent generally terminates at right angles to its longitudinal axis, the use of conventional stents in the region of a vessel bifurcation may result in blocking blood flow of a side branch or fail to repair the bifurcation to the fullest extent necessary.
  • the conventional stent might be placed so that a portion of the stent extends into the pathway of blood flow to a side branch of the bifurcation or extend so far as to completely cover the path of blood flow in a side branch.
  • the conventional stent might alternatively be placed proximal to, but not entirely overlaying the circumference of the ostium to the diseased portion.
  • a stent that consistently overlays the entire circumference of the ostium to a diseased portion, yet does not extend into the junction comprising the bifurcation, may be employed.
  • Such a stent would have the advantage of completely repairing the vessel at the bifurcation without obstructing blood flow in other portions of the bifurcation.
  • such a stent would allow access to all portions of the bifurcated vessel should further interventional treatment be necessary.
  • a stent would have the advantage of completely repairing the vessel origin without protruding into the aorta or complicating repeat access.
  • a conventional stent is implanted in the main vessel so that a portion of the stent is across the side branch, so that stenting of the side branch must occur through the main- vessel stent struts.
  • the main-vessel stent struts must be spread apart to form an opening to the side-branch vessel and then a catheter with a stent is delivered through the opening.
  • the cell to be spread apart must be randomly and blindly selected by recrossing the deployed stent with a wire.
  • the drawback with this approach is there is no way to determine or guarantee that the main- vessel stent struts are properly oriented with respect to the side branch or that the appropriate cell has been selected by the wire for dilatation.
  • the aperture created often does not provide a clear opening and creates a major distortion in the surrounding stent struts.
  • the drawback with this approach is that there is no way to tell if the main-vessel stent struts have been properly oriented and spread apart to provide a clear opening for stenting the side-branch vessel.
  • Another approach to providing a main-vessel stent that does not block access to the ostium of a side-branch vessel is to cut an aperture in the side- wall of the main-vessel stent.
  • the draw-back to this approach is that forming the aperture in this manner interferes with the structural integrity of the stent in the area of the aperture, resulting in reduced strength and scaffolding.
  • the perimeter of the aperture will have open cells and unj oined stent struts presenting a j agged perimeter that may interfere with crossing of the aperture by a guide wire or catheter if subsequent treatment of the side- vessel is required.
  • the side-branch vessel is first stented so that the stent protrudes into the main vessel.
  • a dilatation is then performed in the main vessel to open and stretch the stent struts extending across the lumen from the side-branch vessel.
  • the main-vessel stent is implanted so that its proximal end overlaps with the side-branch vessel.
  • the orientation of the stent elements protruding from the side-branch vessel into the main vessel is completely random.
  • the deployed stent must be recrossed with a wire blindly and arbitrarily selecting a particular stent cell.
  • a "T" stent procedure includes implanting a stent in the side-branch ostium of the bifurcation followed by stenting the main vessel across the side-branch ostium.
  • a stent is implanted in the main vessel with a side-branch stent partially extending into the main vessel creating a double-barreled lumen of the two stents in the main vessel distal to the bifurcation.
  • Another prior art approach includes a so-called "trouser legs and seat” approach, which includes implanting three stents, one stent in the side-branch vessel, a second stent in a distal portion of the main vessel, and a third stent, or a proximal stent, in the main vessel just proximal to the bifurcation. All of the foregoing stent deployment assemblies suffer from the same problems and limitations. Typically, there is uncovered intimal surface segments on the main vessel and side-branch vessels between the stented segments.
  • the invention provides for improved stent designs and stent delivery assemblies for repairing a main vessel and side-branch vessel forming a bifurcation, without compromising blood flow in other portions of the bifurcation, thereby allowing access to all portions of the bifurcated vessels should further interventional treatment be necessary.
  • the stent delivery assemblies of the invention all share the novel feature of containing, in addition to a tracking guide wire, a second positioning wire which affects rotation and precise positioning of the assembly for deployment of the stent.
  • a stent for implanting in the main vessel adjacent to a bifurcation in which a cylindrical member has distal and proximal ends and an outer wall surface therebetween, which can typically be similar to the outer wall surface of stents used in the coronary arteries.
  • An aperture is formed in the outer wall surface of the apertured stent and is sized and positioned on the outer wall surface so that when the apertured stent is implanted in the main vessel, the aperture is aligned with the side- branch vessel providing unrestricted blood flow from the main vessel through to the side-branch vessel. Deployment of the apertured stent is accomplished by a novel stent delivery system adapted specifically for treating bifurcated vessels.
  • the aperture is formed in the outer wall of the stent by configuring the undulating or serpentine pattern of the cylindrical elements of the stent to provide the aperture. Reconfiguring the pattern in this manner provides an aperture perimeter formed of closed stent cells. This construction provides increased strength in the area of the aperture as well as improved scaffolding of the vessel wall surrounding the ostium.
  • the aperture is formed in the stent by adjusting the pattern of stent cells and stent struts so that the size of the stent cell in the region of the stent surrounding the aperture is less than the stent cells in the remainder of the stent.
  • the stent cells in the region including the aperture are half the size of remaining stent cells. The smaller cell size in the region of the aperture results in an aperture perimeter that is smaller and denser, providing both increased scaffolding of the vessel wall surrounding the ostium of a side-branch vessel as well as providing a smoother lumen for accessing the side-branch vessel should subsequent treatment of the side-branch vessel be necessary.
  • the stent delivery system of the present invention further includes a main-vessel catheter for delivering a stent in the main vessel after the side-branch vessel has been stented.
  • the main- vessel catheter includes a tracking guide wire lumen extending through at least a portion thereof, and adapted for receiving a tracking guide wire for slidable movement therein.
  • An expandable member is positioned near the main- vessel catheter distal end for delivering and implanting a main- vessel (apertured) stent in the main vessel.
  • the main- vessel stent includes an aperture on its outer surface which aligns with the side-branch vessel.
  • a positioning guide wire lumen is associated with the expandable member, and is sized for slidably receiving the stent-positioning guide wire.
  • the stent-positioning guide wire slides within the positioning guide wire lumen to orient the expandable member so that it is positioned adjacent to, but not in, the side-branch vessel with the stent aperture facing the side-branch ostium.
  • the main-vessel catheter assembly includes the so- called rapid exchange catheter features which are easily exchangeable for other catheters while the tracking and positioning guide wires remain positioned in the side- branch vessel and the main vessel, respectively.
  • both catheters may be of the "over-the-wire" type.
  • the present invention further includes a method for delivering the main- vessel (apertured) stent in the bifurcated vessel.
  • the proximal end of the main- vessel guide wire is inserted into the distal end of the guide wire lumen of the main-vessel catheter.
  • the main- vessel catheter would then be advanced into the body until the catheter is within one cm or so of the target site.
  • the distal end of the second (integrated, stent-positioning) guide wire which resides in the main-vessel catheter during delivery to the main vessel, is then advanced by having the physician push the positioning wire from outside the body.
  • the distal end of the stent-positioning wire travels through the positioning guide wire lumen and passes underneath the proximal half of the stent until it exits at the site of the stent aperture.
  • the catheter is then advanced distally until resistance is felt from the stent-positioning guide wire pushing up against the ostium of the side- branch vessel indicating that the stent aperture is correctly facing the side-branch vessel ostium. If a stent has already been implanted in the side-branch vessel, this resistance also ensures that the aperture of the main vessel stent is aligned with the proximal end of the side-branch stent.
  • the expandable member on the main- vessel catheter is inflated, thereby expanding and implanting the main-vessel stent into contact with the main vessel, with the aperture in the stent providing a flow path for the blood from the main vessel through to the side-branch vessel without any obstructions.
  • the expandable member is deflated and the main-vessel catheter is removed from the body.
  • the main- vessel catheter is designed so that both the main- vessel guide wire and side- branch wire can be left in their respective vessels should sequential or simultaneous high pressure balloon inflation be required in each of the vessels in order to complete the stenting procedure.
  • the presence of the stent-positioning wire in the stent aperture permits catheter access through this aperture into the side-branch vessel for balloon inflation to smooth out the aperture in the main- vessel stent.
  • This additional step is a matter of physician choice.
  • the main vessel can be stented without the need for stenting the side-branch vessel.
  • An advantage of this embodiment is that a major side branch, not diseased and requiring treatment, exiting from a main vessel requiring stenting, may be protected by the positioning wire while the main vessel is stented. If "snowplowing" compromise or closure of the side-branch vessel occurs with main- vessel stenting, then access is already present and guaranteed for stenting of the side- branch vessel over the wire already in place in the manner described above.
  • the stent to be implanted in the main- vessel is mounted on a main-vessel catheter having an expandable section including two expandable balloons closely spaced together but separated sufficiently so that an exit port formed in the wall of the main-vessel catheter is exposed, allowing a stent- positioning guidewire to exit the catheter.
  • the stent is mounted such that the aperture of the stent is aligned with the exit port, allowing the stent-positioning guidewire to extend out of the exit port and through the stent.
  • the main- vessel catheter is advanced into the body until the catheter is within one cm or so of the target site.
  • the distal end of the stent-positioning guide wire which resides in the main- vessel catheter during delivery to the main vessel, is then advanced by having the physician push the positioning wire from outside the body.
  • the distal end of the stent-positioning wire travels through the positioning guide wire lumen until it exits through the exit port between the balloons at the site of the stent aperture.
  • the catheter is then advanced distally until resistance is felt from the stent-positioning guide wire pushing up against the ostium of the side-branch vessel indicating that the stent aperture is correctly facing the side-branch vessel ostium.
  • the remainder of the method is as described above.
  • the main- vessel catheter is designed so that both the main-vessel guide wire and side-branch wire can be left in their respective vessels should sequential or simultaneous high pressure balloon inflation be required in each of the vessels in order to complete the stenting procedure.
  • a further advantage of this method is that both the main-vessel guide wire and side-branch wires are contained within the catheter body, allowing for use of either an integrated main-vessel/side- branch guide wire system or simply running two separate guide- wires through a central lumen of the catheter.
  • the main- vessel catheter may include two separate lumens to accommodate the main-vessel and side-branch guide wires.
  • FIGURE 1 is an elevational view of a bifurcation in which a prior art "T" stent is in a side-branch ostium followed by the stenting of the main vessel across the branch ostium.
  • FIG. 2 is an elevational view of a bifurcation in which "touching" prior art stents are depicted in which one stent is implanted in the side branch, a second stent implanted in a proximal portion of the main vessel next to the branch stent, with interrupted placement of a third stent implanted more distally in the main vessel.
  • FIG. 3 is an elevational view of a bifurcation depicting "kissing" stents where a portion of one stent is implanted in both the side-branch and the main vessel and adjacent to a second stent implanted in the main vessel creating a double-barreled lumen in the main vessel distal to the bifurcation.
  • FIG.4 is an elevational view of a prior art "trouser legs and seat” stenting approach depicting one stent implanted in the side-branch vessel, a second stent implanted in a proximal portion of the main vessel, and a close deployment of a third stent distal to the bifurcation leaving a small gap between the three stents of an uncovered luminal area.
  • FIG. 5A is a perspective view depicting the main- essel stent of the present invention in which an aperture is formed on the outer surface of at least a portion of the stent.
  • FIG. 5B is a side elevational view of the main-vessel stent of FIG. 5A.
  • FIG. 6 is a side elevational view of another embodiment of the main- vessel stent of the present invention.
  • FIGS .7 A and 7B are cross-sectional views looking down the side-branch vessel at an expanded main vessel prior art stent in which a random, sub-optimal stent cell was entered and expanded.
  • FIGS 7C is a cross-sectional view looking down the side-branch vessel at an expanded main-vessel stent of the present invention showing the alignment between the aperture of the stent and the ostium of the side-branch vessel, allowing for free flow of blood between the vessels.
  • FIGS. 8A-8C depict an elevational view, partially in section, of a main- vessel catheter assembly in which the main vessel stent has an aperture on its outer surface.
  • FIGS. 8G-8I depict an elevational view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS. 8A-8C in which the guide wire lumen is angled to pass under the stent and exit through the stent aperture.
  • FIGS. 8J-8L depict an elevational view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS. 8A-8C in which a portion of the guide wire lumen passes under the stent.
  • FIGS. 9A-9E are elevational views, partially in section, depicting the main- vessel catheter assembly of FIG. 8 A and the main- vessel stent in which two guide wires are used to correctly position the main vessel stent so that the aperture in the stent is aligned with the side-branch vessel.
  • FIG. 10 is an elevation view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS 8 A-C having two expandable balloons separated by a section of catheter having an exit port for a stent-positioning guide wire.
  • FIGS. 1-4 depict prior art devices which include multiple stents being implanted in both the main vessel and a side-branch vessel.
  • a prior art "T" stent is implanted such that a first stent is implanted in the side branch 5 near the ostium of the bifurcation, and a second stent is implanted in the main vessel 6, across the side-branch ostium.
  • portions of the side-branch vessel are left uncovered, and blood flow to the side-branch vessel must necessarily pass through the main-vessel stent, causing possible obstructions or thrombosis.
  • the prior art method includes implanting two stents side by side, such that one stent extends into the side-branch vessel and the main vessel, and the second stent is implanted in the main vessel. This results in a double-barreled lumen which can present problems such as thrombosis, and turbulence in blood flow.
  • a first stent is implanted in the side-branch vessel
  • a second stent is implanted in a proximal portion of the main vessel
  • a third stent is implanted distal to the bifurcation, thereby leaving a small gap between the stents and an uncovered luminal area.
  • Prior art devices that have attempted to first stent the main vessel and randomly select a stent cell to expand for alignment with the side-branch vessel have generally failed.
  • One such approach known as the "monoclonal antibody” approach, as depicted in FIGS. 7A and 7B, depict what can happen when an inappropriate target stent cell is selected randomly and then expanded by a high pressure balloon. As shown in FIG.
  • stent cell 69 which is a sub-optimal cell to expand with the balloon portion of a catheter.
  • stent cell 69 which is a sub-optimal cell to expand with the balloon portion of a catheter.
  • FIG. 7B after balloon expansion in the suboptimal cell 69, entry into the cell with a catheter may be impossible or, if accomplished, expansion of the balloon may be incomplete.
  • the aperture created will be inadequate and major distortion in the adjacent stent struts may occur.
  • Consequences may include subacute thrombosis or restenosis.
  • the aperture of the stent is oriented optimally with respect to the side-branch ostium prior to deployment of the stent using a method of the present invention to be described below.
  • the aperture of the present invention as shown in FIG. 7C guarantees an optimal aperture essentially devoid of stent struts blocking the blood flow path from the main vessel to the side-branch vessel.
  • the stent of the present invention can be implanted in the main vessel where access to a side-branch vessel is necessary to treat a number of angulated ostial lesions including, but not limited to, the following:
  • LAD left anterior descending artery
  • the LAD just distal to, but sparing, the origin of a diagonal. 5.
  • the main vessel stent of the present invention may be used as a solo device, or it can be used in conjunction with an angled stent to treat the foregoing indications.
  • main- vessel stent 20 is configured for deployment in main-vessel 6.
  • Main-vessel stent 20 includes cylindrical member 21 having distal end 22 and proximal end 23.
  • Main-vessel stent 20 includes outer wall surface 24 which extends between distal end 22 and proximal end 23 and incorporates aperture 25 on outer wall surface 24.
  • Aperture 25 is configured so that, upon expansion, it approximates the diameter of the ostium of side-branch vessel 5.
  • main- vessel stent 20 is used in conjunction with a stent implanted in side-branch vessel 5
  • the aperture 25 of main- vessel stent 20 is sized so that, upon expansion, the aperture approximates the diameter of the expanded side- branch stent.
  • aperture 25 is aligned with side-branch vessel 5 and proximal end 14 of proximal angled stent, thereby providing an unrestricted blood flow path from the side- branch vessel to the main vessel.
  • the main-vessel catheter allows selection and positioning of an aperture at the side-branch ostium.
  • a guide wire during main- vessel stent deployment which can be used for additional intervention if necessary .
  • access to a side-branch is through a randomly selected stent element ("cell") and is only possible after deployment of the stent.
  • the precise positioning of aperture 25 is optional and aperture 25 could be positioned either closer to the proximal or distal end of stent 20.
  • Main- vessel stent 20 can be formed from any of a number of materials including, but not limited to, stainless steel alloys, nickel-titanium alloys (the NiTi can be either shape memory or pseudoelastic), tantalum, tungsten, or any number of polymer materials . Such materials of manufacture are known in the art. Further, main- vessel stent 20 can have virtually any pattern including those known to prior art stents. In one configuration, main- vessel stent 20 is formed from a stainless steel material and has a plurality of cylindrical elements connected by connecting members, wherein the cylindrical elements have an undulating or serpentine pattern. Such a stent is disclosed in U.S. Patent No.
  • the aperture 25 is formed in main- vessel stent 25 by specifically configuring the undulating or serpentine pattern of the cylindrical elements of the stent to provide the aperture. Reconfiguring the pattern in this manner provides for increased strength at the border of the aperture as well as improved scaffolding of the vessel wall compared to a stent in which an opening is simply cut into the stent wall leaving open stent cells or unconnected stent struts, or where a random stent cell has been expanded to provide the aperture.
  • One advantage to forming aperture 25 in the manner of the present invention is that aperture 25 has a perimeter formed of closed stent cells.
  • main- vessel stent 30 includes cylindrical member 31 having distal end 32 and proximal end 33.
  • Main- vessel stent 30 includes outer wall surface 34 which extends between distal end 32 and proximal end 33.
  • main-vessel stent 30 includes stent sections 36 which include cylindrical elements having cells of like size.
  • central stent section 37 Located between stent sections 36 is central stent section 37, in which is formed an aperture 35.
  • the cells 38 making up the cylindrical elements comprising central stent section 37 have a reduced size compared to the cells of stent sections 36; for example, each cell in central stent section 37 may be only half the size of a cell of stent sections 36. Reducing the cell size in central stent section 37 provides for a smoother, more uniform boundary of aperture 35, which may be advantageous, especially in those instances where a stent must be implanted in a side-branch vessel after implantation of main- vessel stent 30 in the main- vessel.
  • main- vessel stent 20 For convenience, all references to the main- vessel stent of the present invention will hereinafter refer to main- vessel stent 20. It will be understood, however, that the methods describing the delivery of the main-vessel stents of present invention are equally applicable to each embodiment of the main-vessel stent disclosed herein.
  • Main-vessel stent 20 preferably is a balloon-expandable stent that is mounted on a balloon portion of a catheter and crimped tightly onto the balloon to provide a low profile delivery diameter.
  • the balloon is expanded, thereby expanding the stent beyond its elastic limit into contact with the vessel.
  • the balloon is deflated and the balloon and catheter are withdrawn from the vessel, leaving the stent implanted.
  • Deployment of the main- vessel stent is accomplished by a novel stent delivery system adapted specifically for treating bifurcated vessels.
  • the main- vessel stent could be made to be either balloon expandable or self-expanding.
  • main- vessel 6 also can be stented after stenting the side- branch vessel 5.
  • main- vessel catheter assembly 50 is provided for implanting main- vessel stent 20, as depicted in FIGS. 8 A to 9E.
  • main- vessel catheter 50 includes distal end 51 which is configured for advancement within the patient's vasculature, and proximal end 52 which remains outside the patient.
  • the main- vessel catheter includes guide wire lumen 53A having distal end 53B and side port 53C, which is proximal to the balloon portion of the catheter.
  • Side port 53C is provided in a so-called rapid- exchange catheter system which includes a slit (not shown) as is known in the art.
  • Expandable member 54 is located near distal end 51 of main- vessel catheter 50.
  • expandable member 54 is a non-distensible balloon of the type known in the art for delivering and expanding stents.
  • positioning guide wire lumen 55 A is positioned partly on the catheter shaft and partly on expandable member 54, and is configured for slidably receiving integrated stent-positioning guide wire 56A. Prior to stent delivery, guide wire 56A resides in guide wire lumen 55 A and only during stent delivery is it then advanced into and through angled portion 55B of the lumen.
  • FIGS. 8D-8F This embodiment is identical to that depicted in FIGS. 8A-8C, with the addition of ramp 57 which is mounted on balloon 35 and provides a slight incline for guide wire 56A as it exits guide wire lumen 55 A. As the guide wire slides along ramp 57, distal portion 56B of the guide wire will move radially outwardly which helps position the guide wire and orient it into the side-branch vessel.
  • guide wire lumen 55A passes underneath main- vessel stent 20 and on top of balloon 35.
  • the distal end 55B curves along the balloon so that as guide wire 56B advances out of the distal end 55B of the lumen, it is traveling radially outwardly so that it can more easily locate and advance into the side-branch vessel 5.
  • guide wire lumen 55A is positioned under stent 20 and terminates at distal end 55B in the middle of aperture 25.
  • the distal end 55 A of the guide wire lumen will spring outwardly which facilitates advancing guide wire distal end 41B into the side branch vessel.
  • a distal guide wire lumen 58 is attached to the balloon 35 outer surface and extends from aperture 25 to essentially the distal end of the catheter.
  • guide ire 41 Aremains inposition in main-vessel 6, while the side-branch guide wire 36A is withdrawn from the patient.
  • Main- vessel catheter 50 is backloaded onto guide wire 41 A by inserting proximal end 41B of the wire into the distal end of the catheter and into guide wire lumen 53A.
  • Main-vessel catheter 50 is advanced over guide wire 41 A and viewed under fluoroscopy until main- vessel stent 20 is positioned in main- vessel 6, just proximal to side-branch vessel 5.
  • the distal end 56B of the integrated stent-positioning guide wire 56A is then advanced by the physician pushing on proximal end 56C from outside the body.
  • the distal end 56B of wire 56A advances into and through positioning guide wire lumen 55A and passes underneath the proximal end of the main- vessel stent 20 and exits the angled portion 55B of the lumen and enters side-branch vessel 5.
  • the main-vessel catheter 50 is then advanced distally into the main vessel until resistance is felt from the stent- positioning guide wire 56A pushing up against the ostium of the side-branch vessel.
  • stent-positioning guide wire 56A causes the main-vessel catheter 50, with main- vessel stent 20 thereon, to rotate so that aperture 25 is facing the side-branch vessel 5 ostium and proximal angled stent 10 already implanted.
  • Expandable member 54 which is typically a non-distensible expandable balloon, is inflated thereby expanding main-vessel stent 20 into contact with main- vessel 6. Aperture 25 correspondingly expands and when properly aligned, provides a blood flow path between aperture 25 and proximal angled stent 10 implanted in side- branch vessel 5. As can be seen in FIGS. 8A-8I and 9A-9D, positioning guide wire lumen 55A is positioned on expandable member 54, such that when the expandable member is inflated, positioning guide wire lumen 55A does not interfere with implanting main-vessel stent 20. After the main- vessel stent is implanted in the main vessel, expandable member 54 is deflated, and main- vessel catheter 50 withdrawn from the patient.
  • tracking guide wire 41A is advanced through guide wire lumen 55 A and guide wire lumen 58 so that it advances distally of the distal end 51 of the catheter.
  • guide wire distal end 41B is advanced into the main vessel so that it is distal of the side-branch vessel.
  • Guide wire 56A which until this point has remained within guide wire lumen 53A (see FIG. 8K), is advanced distally as depicted in FIG. 8L and advanced into the main vessel distally of the side-branch vessel.
  • Guide wire 41A is then withdrawn proximally through guide wire lumen 58 until guide wire distal end 41B is able to exit guide wire lumen distal end 55B, as shown in FIG. 8L. Since guide wire lumen 55B is preformed and has bias, it will spring outwardly. Guide wire 41 A can then be advanced into the side-branch vessel for further positioning. As the catheter 50 is advanced over the guide wires, distal portion 4 IB of the guide wire will push against the ostium of the side-branch vessel thereby insuring the location of main- vessel stent 20, and importantly aperture 25 will align with the opening to the side-branch vessel 5.
  • positioning guide wire lumen 55 A on main-vessel catheter 50, can be radi opaque, or have a radiopaque marker associated therewith so that it is visible under fluoroscopy .
  • positioning guide wire 56A for positioning main- vessel stent 20 is either radiopaque or has radiopaque portions, such as gold markers, to assist in positioning and orienting the catheter and stent during implantation and deployment.
  • main- vessel catheter 50 has been described herein as being of the rapid-exchange type, it also can be of a conventional over-the-wire-type catheter.
  • the guide wire lumen extends from the distal end of the catheter to the proximal end with no side port as is found in the rapid-exchange-type catheters.
  • Typical of over-the-wire-type catheters is the type disclosed in U.S. Patent Nos.4,323 ,071 and B 1 4,323 ,071 , which are incorporated herein by reference, and are commonly assigned and commonly owned by Advanced Cardiovascular Systems, Inc., Santa Clara, California.
  • main- vessel stent 20 may be mounted on a main- vessel catheter 100.
  • main- vessel catheter 100 includes an expandable portion 105 located near distal end 110 of main-vessel catheter 100.
  • Main-vessel catheter 100 includes guide wire lumen 115 which extends to port 120 located at distal end 110 of the main- vessel catheter.
  • Expandable portion 105 includes a proximal balloon 125 and a distal balloon 130 separated by exit notch 135.
  • Exit notch 135 is formed from the body of main- vessel catheter 100, and may have the same, a lesser or a greater diameter than the remainder of the catheter body.
  • the main- vessel catheter 100 also has a stent-positioning guide wire lumen 140 that extends through the main- vessel catheter to exit port 145 located in exit notch 135.
  • Main- vessel catheter 100 may be configured as a so-called rapid- exchange catheter system which includes a slit (not shown) as is known in the art, and appropriate side ports for introduction of the guide wire and stent-positioning guide wire (not shown).
  • main- vessel catheter 100 may be configured as an over-the-wire catheter system.
  • proximal balloon 125 and distal balloon 130 are non-distensible balloons of the type known in the art for delivering and expanding stents.
  • Main- vessel stent 20 is mounted on expandable portion 105 of main- vessel catheter 100 by crimping stent 20 over proximal balloon 125 and distal balloon 130 and orienting stent 20 so that aperture 25 is positioned over exit port 145 in exit notch 135 of main- vessel catheter 100 to allow a stent-positioning guide wire to extend out of exit port 145, through aperture 25 and into the ostium of side-branch vessel 5.
  • exit notch 135 includes a marker band 150 to aid in positioning aperture 25 of main- vessel stent 20 in the desired location relative to the ostium of side- branch vessel 5.
  • main- vessel catheter 100 The procedure for positioning and implanting main- vessel stent 20 using main- vessel catheter 100 is similar to the method described above with reference to FIGS. 8A-8C and 9A-9D. Expansion of stent 20, however, differs from the method described above since expandable portion 105 of main- vessel catheter 100 includes proximal balloon 125 and distal balloon 130 separated by exit notch 135.
  • expandable portion 105 of main- vessel catheter 100 includes proximal balloon 125 and distal balloon 130 separated by exit notch 135.
  • proximal balloon 125 and distal balloon 130 are expanded either simultaneously or separately, depending on the physicians choice.
  • main- vessel catheter 100 is pulled back by the physician by pulling a portion of the catheter from the patient's body.
  • Main- vessel catheter 100 is pulled back just sufficiently to position the distal balloon 130 in the center of stent 20 so that the portion of stent 20 originally positioned over exit notch 135 may be expanded.
  • distal balloon 130 is then deflated, and main- vessel catheter 100 is withdrawn from the patient.
  • the design of main-catheter 100 allows both the main and stent-positioning guide wires to remain in the main- essel and side-branch vessels in case further stent deployment or expansion are necessary.

Abstract

An apparatus and method is provided for stenting bifurcated vessels. A main-vessel stent and delivery system is provided for implanting a stent in the main vessel of a bifurcated vessel, wherein the main-vessel stent has an aperture bordered by closed stent cells that aligns with the opening to a side-branch vessel to permit substantially unobstructed blood flow between the main vessel and the side-branch vessel. The delivery system includes a catheter assembly having distal and proximal balloons separated by a positioning guide wire exit port located at the distal end of the catheter. The catheter assembly is advanced over a pair of guide wires for delivering, appropriately orienting, and implanting the main-vessel stent.

Description

STENT AND CATHETER ASSEMBLY AND METHOD FOR TREATING BIFURCATED VESSELS
BACKGROUND OF THE INVENTION
The invention relates to stent deployment assemblies for use at a bifurcation and, more particularly, a catheter assembly for implanting one or more stents for repairing bifurcations, the aorto-ostium, and bifurcated blood vessels that are diseased, and a method and apparatus for delivery and implantation. Stents conventionally repair blood vessels that are diseased and are generally hollow and cylindrical in shape and have terminal ends that are generally perpendicular to its longitudinal axis. In use, the conventional stent is positioned at the diseased area of a vessel and, after placement, the stent provides an unobstructed pathway for blood flow. Repair of vessels that are diseased at a bifurcation is particularly challenging since the stent must overlay the entire diseased area at the bifurcation, yet not itself compromise blood flow. Therefore, the stent must, without compromising blood flow, overlay the entire circumference of the ostium to a diseased portion and extend to a point within and beyond the diseased portion. Where the stent does not overlay the entire circumference of the ostium to the diseased portion, the stent fails to completely repair the bifurcated vessel. Where the stent overlays the entire circumference of the ostium to the diseased portion, yet extends into the junction comprising the bifurcation, the diseased area is repaired, but blood flow may be compromised in other portions of the bifurcation. Unapposed stent elements may promote lumen compromise during neointimalization and healing, producing restenosis and requiring further procedures. Moreover, by extending into the junction comprising the bifurcation, the stent may block access to portions of the bifurcated vessel that require performance of further interventional procedures. Similar problems are encountered when vessels are diseased at their angled origin from the aorta as in the ostium of a right coronary or a vein graft. In this circumstance, a stent overlying the entire circumference of the ostium extends back into the aorta, creating problems, including those for repeat catheter access to the vessel involved in further interventional procedures.
Conventional stents are designed to repair areas of blood vessels that are removed from bifurcations and, since a conventional stent generally terminates at right angles to its longitudinal axis, the use of conventional stents in the region of a vessel bifurcation may result in blocking blood flow of a side branch or fail to repair the bifurcation to the fullest extent necessary. The conventional stent might be placed so that a portion of the stent extends into the pathway of blood flow to a side branch of the bifurcation or extend so far as to completely cover the path of blood flow in a side branch. The conventional stent might alternatively be placed proximal to, but not entirely overlaying the circumference of the ostium to the diseased portion. Such a position of the conventional stent results in a bifurcation that is not completely repaired. The only conceivable situation that the conventional stent, having right- angled terminal ends, could be placed where the entire circumference of the ostium is repaired without compromising blood flow, is where the bifurcation is formed of right angles. In such scenarios, extremely precise positioning of the conventional stent is required. This extremely precise positioning of the conventional stent may result with the right-angled terminal ends of the conventional stent overlying the entire circumference of the ostium to the diseased portion without extending into a side branch, thereby completely repairing the right-angled bifurcation.
To circumvent or overcome the problems and limitations associated with conventional stents in the context of repairing diseased bifurcated vessels, a stent that consistently overlays the entire circumference of the ostium to a diseased portion, yet does not extend into the junction comprising the bifurcation, may be employed. Such a stent would have the advantage of completely repairing the vessel at the bifurcation without obstructing blood flow in other portions of the bifurcation. In addition, such a stent would allow access to all portions of the bifurcated vessel should further interventional treatment be necessary. In a situation involving disease in the origin of an angulated aorto-ostial vessel, such a stent would have the advantage of completely repairing the vessel origin without protruding into the aorta or complicating repeat access.
In addition to the problems encountered by using the prior art stents to treat bifurcations, the delivery platform for implanting such stents has presented numerous problems. For example, a conventional stent is implanted in the main vessel so that a portion of the stent is across the side branch, so that stenting of the side branch must occur through the main- vessel stent struts. In this method, commonly referred to in the art as the "monoclonal antibody" approach, the main-vessel stent struts must be spread apart to form an opening to the side-branch vessel and then a catheter with a stent is delivered through the opening. The cell to be spread apart must be randomly and blindly selected by recrossing the deployed stent with a wire. The drawback with this approach is there is no way to determine or guarantee that the main- vessel stent struts are properly oriented with respect to the side branch or that the appropriate cell has been selected by the wire for dilatation. The aperture created often does not provide a clear opening and creates a major distortion in the surrounding stent struts. The drawback with this approach is that there is no way to tell if the main-vessel stent struts have been properly oriented and spread apart to provide a clear opening for stenting the side-branch vessel.
Another approach to providing a main-vessel stent that does not block access to the ostium of a side-branch vessel is to cut an aperture in the side- wall of the main-vessel stent. The draw-back to this approach is that forming the aperture in this manner interferes with the structural integrity of the stent in the area of the aperture, resulting in reduced strength and scaffolding. Additionally, where such an aperture is cut into a stent having otherwise closed cells formed from stent struts, the perimeter of the aperture will have open cells and unj oined stent struts presenting a j agged perimeter that may interfere with crossing of the aperture by a guide wire or catheter if subsequent treatment of the side- vessel is required.
In another prior art method for treating bifurcated vessels, commonly referred to as the "Culotte technique," the side-branch vessel is first stented so that the stent protrudes into the main vessel. A dilatation is then performed in the main vessel to open and stretch the stent struts extending across the lumen from the side-branch vessel. Thereafter, the main-vessel stent is implanted so that its proximal end overlaps with the side-branch vessel. One of the drawbacks of this approach is that the orientation of the stent elements protruding from the side-branch vessel into the main vessel is completely random. Furthermore the deployed stent must be recrossed with a wire blindly and arbitrarily selecting a particular stent cell. When dilating the main vessel stretching the stent struts is therefore random, leaving the possibility of restricted access, incomplete lumen dilatation, and major stent distortion. In another prior art device and method of implanting stents, a "T" stent procedure includes implanting a stent in the side-branch ostium of the bifurcation followed by stenting the main vessel across the side-branch ostium. In another prior art procedure, known as "kissing" stents, a stent is implanted in the main vessel with a side-branch stent partially extending into the main vessel creating a double-barreled lumen of the two stents in the main vessel distal to the bifurcation. Another prior art approach includes a so-called "trouser legs and seat" approach, which includes implanting three stents, one stent in the side-branch vessel, a second stent in a distal portion of the main vessel, and a third stent, or a proximal stent, in the main vessel just proximal to the bifurcation. All of the foregoing stent deployment assemblies suffer from the same problems and limitations. Typically, there is uncovered intimal surface segments on the main vessel and side-branch vessels between the stented segments. An uncovered flap or fold in the intima or plaque will invite a "snowplow" effect, representing a substantial risk for subacute thrombosis, and the increased risk of the development of restenosis. Further, where portions of the stent are left unapposed within the lumen, the risk for subacute thrombosis or the development of restenosis again is increased. The prior art stents and delivery assemblies for treating bifurcations are difficult to use, making successful placement nearly impossible. Further, even where placement has been successful, the side-branch vessel can be "jailed" or covered so that there is impaired access to the stented area for subsequent intervention. The present invention solves these and other problems as will be shown.
In addition to problems encountered in treating disease involving bifurcations for vessel origins, difficulty is also encountered in treating disease confined to a vessel segment but extending very close to a distal branch point or bifurcation which is not diseased and does not require treatment. In such circumstances, very precise placement of a stent covering the distal segment, but not extending into the ostium of the distal side-branch, may be difficult or impossible. The present invention also offers a solution to this problem. References to distal and proximal herein shall mean: the proximal direction is moving away from or out of the patient and distal is moving toward or into the patient. These definitions will apply with reference to body lumens and apparatus, such as catheters, guide wires, and stents.
SUMMARY OF THE INVENTION
The invention provides for improved stent designs and stent delivery assemblies for repairing a main vessel and side-branch vessel forming a bifurcation, without compromising blood flow in other portions of the bifurcation, thereby allowing access to all portions of the bifurcated vessels should further interventional treatment be necessary. The stent delivery assemblies of the invention all share the novel feature of containing, in addition to a tracking guide wire, a second positioning wire which affects rotation and precise positioning of the assembly for deployment of the stent.
A stent is provided for implanting in the main vessel adjacent to a bifurcation in which a cylindrical member has distal and proximal ends and an outer wall surface therebetween, which can typically be similar to the outer wall surface of stents used in the coronary arteries. An aperture is formed in the outer wall surface of the apertured stent and is sized and positioned on the outer wall surface so that when the apertured stent is implanted in the main vessel, the aperture is aligned with the side- branch vessel providing unrestricted blood flow from the main vessel through to the side-branch vessel. Deployment of the apertured stent is accomplished by a novel stent delivery system adapted specifically for treating bifurcated vessels.
The aperture is formed in the outer wall of the stent by configuring the undulating or serpentine pattern of the cylindrical elements of the stent to provide the aperture. Reconfiguring the pattern in this manner provides an aperture perimeter formed of closed stent cells. This construction provides increased strength in the area of the aperture as well as improved scaffolding of the vessel wall surrounding the ostium.
In general, the aperture is formed in the stent by adjusting the pattern of stent cells and stent struts so that the size of the stent cell in the region of the stent surrounding the aperture is less than the stent cells in the remainder of the stent. Preferably, the stent cells in the region including the aperture are half the size of remaining stent cells. The smaller cell size in the region of the aperture results in an aperture perimeter that is smaller and denser, providing both increased scaffolding of the vessel wall surrounding the ostium of a side-branch vessel as well as providing a smoother lumen for accessing the side-branch vessel should subsequent treatment of the side-branch vessel be necessary.
The stent delivery system of the present invention further includes a main-vessel catheter for delivering a stent in the main vessel after the side-branch vessel has been stented. The main- vessel catheter includes a tracking guide wire lumen extending through at least a portion thereof, and adapted for receiving a tracking guide wire for slidable movement therein. An expandable member is positioned near the main- vessel catheter distal end for delivering and implanting a main- vessel (apertured) stent in the main vessel. The main- vessel stent includes an aperture on its outer surface which aligns with the side-branch vessel. A positioning guide wire lumen is associated with the expandable member, and is sized for slidably receiving the stent-positioning guide wire. The stent-positioning guide wire slides within the positioning guide wire lumen to orient the expandable member so that it is positioned adjacent to, but not in, the side-branch vessel with the stent aperture facing the side-branch ostium. In one embodiment, the main-vessel catheter assembly includes the so- called rapid exchange catheter features which are easily exchangeable for other catheters while the tracking and positioning guide wires remain positioned in the side- branch vessel and the main vessel, respectively. In an alternate embodiment, both catheters may be of the "over-the-wire" type.
The present invention further includes a method for delivering the main- vessel (apertured) stent in the bifurcated vessel.
In the event that the main vessel is to be stented (with the stent placed across the bifurcation site), the proximal end of the main- vessel guide wire is inserted into the distal end of the guide wire lumen of the main-vessel catheter. The main- vessel catheter would then be advanced into the body until the catheter is within one cm or so of the target site. The distal end of the second (integrated, stent-positioning) guide wire, which resides in the main-vessel catheter during delivery to the main vessel, is then advanced by having the physician push the positioning wire from outside the body. The distal end of the stent-positioning wire travels through the positioning guide wire lumen and passes underneath the proximal half of the stent until it exits at the site of the stent aperture. The catheter is then advanced distally until resistance is felt from the stent-positioning guide wire pushing up against the ostium of the side- branch vessel indicating that the stent aperture is correctly facing the side-branch vessel ostium. If a stent has already been implanted in the side-branch vessel, this resistance also ensures that the aperture of the main vessel stent is aligned with the proximal end of the side-branch stent. Thereafter, the expandable member on the main- vessel catheter is inflated, thereby expanding and implanting the main-vessel stent into contact with the main vessel, with the aperture in the stent providing a flow path for the blood from the main vessel through to the side-branch vessel without any obstructions. The expandable member is deflated and the main-vessel catheter is removed from the body. The main- vessel catheter is designed so that both the main- vessel guide wire and side- branch wire can be left in their respective vessels should sequential or simultaneous high pressure balloon inflation be required in each of the vessels in order to complete the stenting procedure. The presence of the stent-positioning wire in the stent aperture permits catheter access through this aperture into the side-branch vessel for balloon inflation to smooth out the aperture in the main- vessel stent. This additional step is a matter of physician choice. Utilizing this method, the main vessel can be stented without the need for stenting the side-branch vessel. An advantage of this embodiment is that a major side branch, not diseased and requiring treatment, exiting from a main vessel requiring stenting, may be protected by the positioning wire while the main vessel is stented. If "snowplowing" compromise or closure of the side-branch vessel occurs with main- vessel stenting, then access is already present and guaranteed for stenting of the side- branch vessel over the wire already in place in the manner described above. This will allow confident stenting of a main vessel segment containing a major side branch. In this usage, only if compromise or occlusion of the side branch occurs, will additional stenting of the side branch be required. In an alternative embodiment, the stent to be implanted in the main- vessel is mounted on a main-vessel catheter having an expandable section including two expandable balloons closely spaced together but separated sufficiently so that an exit port formed in the wall of the main-vessel catheter is exposed, allowing a stent- positioning guidewire to exit the catheter. In normal use, the stent is mounted such that the aperture of the stent is aligned with the exit port, allowing the stent-positioning guidewire to extend out of the exit port and through the stent. In this embodiment, the main- vessel catheter is advanced into the body until the catheter is within one cm or so of the target site. The distal end of the stent-positioning guide wire, which resides in the main- vessel catheter during delivery to the main vessel, is then advanced by having the physician push the positioning wire from outside the body. The distal end of the stent-positioning wire travels through the positioning guide wire lumen until it exits through the exit port between the balloons at the site of the stent aperture. The catheter is then advanced distally until resistance is felt from the stent-positioning guide wire pushing up against the ostium of the side-branch vessel indicating that the stent aperture is correctly facing the side-branch vessel ostium. The remainder of the method is as described above. The main- vessel catheter is designed so that both the main-vessel guide wire and side-branch wire can be left in their respective vessels should sequential or simultaneous high pressure balloon inflation be required in each of the vessels in order to complete the stenting procedure. A further advantage of this method is that both the main-vessel guide wire and side-branch wires are contained within the catheter body, allowing for use of either an integrated main-vessel/side- branch guide wire system or simply running two separate guide- wires through a central lumen of the catheter. Alternatively, the main- vessel catheter may include two separate lumens to accommodate the main-vessel and side-branch guide wires.
Other features and advantages of the present invention will become apparent from the following detailed description, taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS FIGURE 1 is an elevational view of a bifurcation in which a prior art "T" stent is in a side-branch ostium followed by the stenting of the main vessel across the branch ostium. FIG. 2 is an elevational view of a bifurcation in which "touching" prior art stents are depicted in which one stent is implanted in the side branch, a second stent implanted in a proximal portion of the main vessel next to the branch stent, with interrupted placement of a third stent implanted more distally in the main vessel.
FIG. 3 is an elevational view of a bifurcation depicting "kissing" stents where a portion of one stent is implanted in both the side-branch and the main vessel and adjacent to a second stent implanted in the main vessel creating a double-barreled lumen in the main vessel distal to the bifurcation.
FIG.4 is an elevational view of a prior art "trouser legs and seat" stenting approach depicting one stent implanted in the side-branch vessel, a second stent implanted in a proximal portion of the main vessel, and a close deployment of a third stent distal to the bifurcation leaving a small gap between the three stents of an uncovered luminal area.
FIG. 5A is a perspective view depicting the main- essel stent of the present invention in which an aperture is formed on the outer surface of at least a portion of the stent.
FIG. 5B is a side elevational view of the main-vessel stent of FIG. 5A.
FIG. 6 is a side elevational view of another embodiment of the main- vessel stent of the present invention. FIGS .7 A and 7B are cross-sectional views looking down the side-branch vessel at an expanded main vessel prior art stent in which a random, sub-optimal stent cell was entered and expanded.
FIGS 7C is a cross-sectional view looking down the side-branch vessel at an expanded main-vessel stent of the present invention showing the alignment between the aperture of the stent and the ostium of the side-branch vessel, allowing for free flow of blood between the vessels.
FIGS. 8A-8C depict an elevational view, partially in section, of a main- vessel catheter assembly in which the main vessel stent has an aperture on its outer surface. FIGS . 8D- 8F depict an elevational view, partially in section, of the main- vessel catheter of FIGS. 8A-8C with a ramp to help orient and advance the guide wire through the aperture in the main-vessel stent.
FIGS. 8G-8I depict an elevational view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS. 8A-8C in which the guide wire lumen is angled to pass under the stent and exit through the stent aperture.
FIGS. 8J-8L depict an elevational view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS. 8A-8C in which a portion of the guide wire lumen passes under the stent. FIGS. 9A-9E are elevational views, partially in section, depicting the main- vessel catheter assembly of FIG. 8 A and the main- vessel stent in which two guide wires are used to correctly position the main vessel stent so that the aperture in the stent is aligned with the side-branch vessel. FIG. 10 is an elevation view, partially in section, of an alternative embodiment of the main- vessel catheter of FIGS 8 A-C having two expandable balloons separated by a section of catheter having an exit port for a stent-positioning guide wire.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention includes an assembly and method for treating bifurcations in, for example, the coronary arteries, veins, arteries, and other vessels in the body. Prior art attempts at implanting intravascular stents in a bifurcation have proved less than satisfactory. For example, FIGS. 1-4 depict prior art devices which include multiple stents being implanted in both the main vessel and a side-branch vessel. In FIG. 1, a prior art "T" stent is implanted such that a first stent is implanted in the side branch 5 near the ostium of the bifurcation, and a second stent is implanted in the main vessel 6, across the side-branch ostium. With this approach, portions of the side-branch vessel are left uncovered, and blood flow to the side-branch vessel must necessarily pass through the main-vessel stent, causing possible obstructions or thrombosis.
Referring to FIG. 2, three prior art stents are required to stent the bifurcation. In FIG. 3, the prior art method includes implanting two stents side by side, such that one stent extends into the side-branch vessel and the main vessel, and the second stent is implanted in the main vessel. This results in a double-barreled lumen which can present problems such as thrombosis, and turbulence in blood flow. Referring to the FIG. 4 prior art device, a first stent is implanted in the side-branch vessel, a second stent is implanted in a proximal portion of the main vessel, and a third stent is implanted distal to the bifurcation, thereby leaving a small gap between the stents and an uncovered luminal area. Prior art devices that have attempted to first stent the main vessel and randomly select a stent cell to expand for alignment with the side-branch vessel, have generally failed. One such approach, known as the "monoclonal antibody" approach, as depicted in FIGS. 7A and 7B, depict what can happen when an inappropriate target stent cell is selected randomly and then expanded by a high pressure balloon. As shown in FIG. 7 A, which is a view looking down side-branch vessel 5 in partial cross- section at a prior art stent 68, the physician randomly selects stent cell 69 which is a sub-optimal cell to expand with the balloon portion of a catheter. As depicted in FIG. 7B, after balloon expansion in the suboptimal cell 69, entry into the cell with a catheter may be impossible or, if accomplished, expansion of the balloon may be incomplete. The aperture created will be inadequate and major distortion in the adjacent stent struts may occur. Consequences may include subacute thrombosis or restenosis. With the present invention, as shown in FIGS. 7C, the aperture of the stent is oriented optimally with respect to the side-branch ostium prior to deployment of the stent using a method of the present invention to be described below. The aperture of the present invention as shown in FIG. 7C, guarantees an optimal aperture essentially devoid of stent struts blocking the blood flow path from the main vessel to the side-branch vessel.
All of the prior art devices depicted in FIGS . 1 -4 and 7A-7B have various drawbacks which have been solved by the present invention. The stent of the present invention can be implanted in the main vessel where access to a side-branch vessel is necessary to treat a number of angulated ostial lesions including, but not limited to, the following:
1. The ostium of a left anterior descending artery (LAD) where there is a circumflex or trifurcation vessel at less than 90° in its departure from the LAD.
2. The ostium of the circumflex artery or a trifurcation in a similar situation as number 1.
3. The ostium of a sizeable diagonal.
4. The LAD just distal to, but sparing, the origin of a diagonal. 5. The ostium of a circumflex marginal artery with an angulated take-off.
6. Disease in the circumflex artery just distal to a marginal take-off, but sparing that take-off.
7. The aorta-ostium of a right coronary artery with an angled takeoff.
8. The origin of an angulated posterior descending artery.
9. The origin of an L V extension branch just at and beyond the crux, sparing the posterior descending artery.
10. The ostium of an angulated vein graft origin.
11. Any of many of the above locations in conjunction with involvement of the bifurcation and an alternate vessel.
The main vessel stent of the present invention may be used as a solo device, or it can be used in conjunction with an angled stent to treat the foregoing indications.
In keeping with the invention, as depicted in FIGS. 5A and 5B, main- vessel stent 20 is configured for deployment in main-vessel 6. Main-vessel stent 20 includes cylindrical member 21 having distal end 22 and proximal end 23. Main-vessel stent 20 includes outer wall surface 24 which extends between distal end 22 and proximal end 23 and incorporates aperture 25 on outer wall surface 24. Aperture 25 is configured so that, upon expansion, it approximates the diameter of the ostium of side-branch vessel 5. Where main- essel stent 20 is used in conjunction with a stent implanted in side-branch vessel 5, the aperture 25 of main- vessel stent 20 is sized so that, upon expansion, the aperture approximates the diameter of the expanded side- branch stent. When main- vessel stent 20 is implanted and expanded into contact with main- vessel 6, aperture 25 is aligned with side-branch vessel 5 and proximal end 14 of proximal angled stent, thereby providing an unrestricted blood flow path from the side- branch vessel to the main vessel. Unlike the prior art, the main-vessel catheter allows selection and positioning of an aperture at the side-branch ostium. Furthermore, it provides for the positioning of a guide wire during main- vessel stent deployment which can be used for additional intervention if necessary . In the prior art techniques access to a side-branch is through a randomly selected stent element ("cell") and is only possible after deployment of the stent. The precise positioning of aperture 25 is optional and aperture 25 could be positioned either closer to the proximal or distal end of stent 20.
Main- vessel stent 20 can be formed from any of a number of materials including, but not limited to, stainless steel alloys, nickel-titanium alloys (the NiTi can be either shape memory or pseudoelastic), tantalum, tungsten, or any number of polymer materials . Such materials of manufacture are known in the art. Further, main- vessel stent 20 can have virtually any pattern including those known to prior art stents. In one configuration, main- vessel stent 20 is formed from a stainless steel material and has a plurality of cylindrical elements connected by connecting members, wherein the cylindrical elements have an undulating or serpentine pattern. Such a stent is disclosed in U.S. Patent No. 5,514,154 and is manufactured and sold by Advanced Cardiovascular Systems, Inc., Santa Clara, California. The stent is sold under the tradename MultiLink® Stent. Such stents can be modified to include the novel features of main- vessel stent 20 (the aperture).
As is depicted in FIGS. 5A and 5B, the aperture 25 is formed in main- vessel stent 25 by specifically configuring the undulating or serpentine pattern of the cylindrical elements of the stent to provide the aperture. Reconfiguring the pattern in this manner provides for increased strength at the border of the aperture as well as improved scaffolding of the vessel wall compared to a stent in which an opening is simply cut into the stent wall leaving open stent cells or unconnected stent struts, or where a random stent cell has been expanded to provide the aperture. One advantage to forming aperture 25 in the manner of the present invention is that aperture 25 has a perimeter formed of closed stent cells. This structure provides for improved stent strength in the border of the stent surrounding the aperture, and also provides improved scaffolding of the main-vessel wall 6 surrounding the ostium of side-branch vessel 6. The closed stent cells surrounding aperture 25 also provide a smother, more regular aperture boundary that is less likely to interfere with subsequent crossing of aperture 25 by a guide wire or catheter should subsequent treatment of side-branch vessel 5 be required. In an another embodiment depicted in FIG. 6, main- vessel stent 30 includes cylindrical member 31 having distal end 32 and proximal end 33. Main- vessel stent 30 includes outer wall surface 34 which extends between distal end 32 and proximal end 33. In this embodiment, main-vessel stent 30 includes stent sections 36 which include cylindrical elements having cells of like size. Located between stent sections 36 is central stent section 37, in which is formed an aperture 35. The cells 38 making up the cylindrical elements comprising central stent section 37 have a reduced size compared to the cells of stent sections 36; for example, each cell in central stent section 37 may be only half the size of a cell of stent sections 36. Reducing the cell size in central stent section 37 provides for a smoother, more uniform boundary of aperture 35, which may be advantageous, especially in those instances where a stent must be implanted in a side-branch vessel after implantation of main- vessel stent 30 in the main- vessel.
For convenience, all references to the main- vessel stent of the present invention will hereinafter refer to main- vessel stent 20. It will be understood, however, that the methods describing the delivery of the main-vessel stents of present invention are equally applicable to each embodiment of the main-vessel stent disclosed herein.
Main-vessel stent 20 preferably is a balloon-expandable stent that is mounted on a balloon portion of a catheter and crimped tightly onto the balloon to provide a low profile delivery diameter. After the catheter is positioned so that the stent and the balloon portion of the catheter are positioned either in the side-branch or the main vessel, the balloon is expanded, thereby expanding the stent beyond its elastic limit into contact with the vessel. Thereafter, the balloon is deflated and the balloon and catheter are withdrawn from the vessel, leaving the stent implanted. Deployment of the main- vessel stent is accomplished by a novel stent delivery system adapted specifically for treating bifurcated vessels. The main- vessel stent could be made to be either balloon expandable or self-expanding.
If necessary, main- vessel 6 also can be stented after stenting the side- branch vessel 5. In that regard, and in keeping with the invention, main- vessel catheter assembly 50 is provided for implanting main- vessel stent 20, as depicted in FIGS. 8 A to 9E. In one embodiment, as shown in FIGS. 8A-8C, main- vessel catheter 50 includes distal end 51 which is configured for advancement within the patient's vasculature, and proximal end 52 which remains outside the patient. The main- vessel catheter includes guide wire lumen 53A having distal end 53B and side port 53C, which is proximal to the balloon portion of the catheter. Side port 53C is provided in a so-called rapid- exchange catheter system which includes a slit (not shown) as is known in the art. Expandable member 54 is located near distal end 51 of main- vessel catheter 50. Typically, expandable member 54 is a non-distensible balloon of the type known in the art for delivering and expanding stents. In further keeping with the invention, positioning guide wire lumen 55 A is positioned partly on the catheter shaft and partly on expandable member 54, and is configured for slidably receiving integrated stent-positioning guide wire 56A. Prior to stent delivery, guide wire 56A resides in guide wire lumen 55 A and only during stent delivery is it then advanced into and through angled portion 55B of the lumen. Other embodiments for implanting main-vessel stent 20 in main-vessel
6 are depicted, for example, in FIGS. 8D-8F. This embodiment is identical to that depicted in FIGS. 8A-8C, with the addition of ramp 57 which is mounted on balloon 35 and provides a slight incline for guide wire 56A as it exits guide wire lumen 55 A. As the guide wire slides along ramp 57, distal portion 56B of the guide wire will move radially outwardly which helps position the guide wire and orient it into the side-branch vessel. In another embodiment for implanting the main- vessel stent in the main vessel, as depicted in FIGS. 8G-8I, guide wire lumen 55A passes underneath main- vessel stent 20 and on top of balloon 35. The distal end 55B curves along the balloon so that as guide wire 56B advances out of the distal end 55B of the lumen, it is traveling radially outwardly so that it can more easily locate and advance into the side-branch vessel 5. In still another embodiment for implanting main-vessel stent 20 in the main- vessel 6, as depicted in FIGS. 8J-8L, guide wire lumen 55A is positioned under stent 20 and terminates at distal end 55B in the middle of aperture 25. The distal end 55 A of the guide wire lumen will spring outwardly which facilitates advancing guide wire distal end 41B into the side branch vessel. A distal guide wire lumen 58 is attached to the balloon 35 outer surface and extends from aperture 25 to essentially the distal end of the catheter.
In one method of implanting main- vessel stent 20 in main-vessel 6, as depicted in FIGS. 8A-8I and9A-9D, guide ire 41 Aremains inposition in main-vessel 6, while the side-branch guide wire 36A is withdrawn from the patient. Main- vessel catheter 50 is backloaded onto guide wire 41 A by inserting proximal end 41B of the wire into the distal end of the catheter and into guide wire lumen 53A. Main-vessel catheter 50 is advanced over guide wire 41 A and viewed under fluoroscopy until main- vessel stent 20 is positioned in main- vessel 6, just proximal to side-branch vessel 5. The distal end 56B of the integrated stent-positioning guide wire 56A is then advanced by the physician pushing on proximal end 56C from outside the body. The distal end 56B of wire 56A advances into and through positioning guide wire lumen 55A and passes underneath the proximal end of the main- vessel stent 20 and exits the angled portion 55B of the lumen and enters side-branch vessel 5. The main-vessel catheter 50 is then advanced distally into the main vessel until resistance is felt from the stent- positioning guide wire 56A pushing up against the ostium of the side-branch vessel. The stiffness of stent-positioning guide wire 56A causes the main-vessel catheter 50, with main- vessel stent 20 thereon, to rotate so that aperture 25 is facing the side-branch vessel 5 ostium and proximal angled stent 10 already implanted.
Expandable member 54, which is typically a non-distensible expandable balloon, is inflated thereby expanding main-vessel stent 20 into contact with main- vessel 6. Aperture 25 correspondingly expands and when properly aligned, provides a blood flow path between aperture 25 and proximal angled stent 10 implanted in side- branch vessel 5. As can be seen in FIGS. 8A-8I and 9A-9D, positioning guide wire lumen 55A is positioned on expandable member 54, such that when the expandable member is inflated, positioning guide wire lumen 55A does not interfere with implanting main-vessel stent 20. After the main- vessel stent is implanted in the main vessel, expandable member 54 is deflated, and main- vessel catheter 50 withdrawn from the patient.
In an alternative method of implanting main- vessel stent 20 in main- vessel 6 as depicted in FIGS. 8J-8L, tracking guide wire 41A is advanced through guide wire lumen 55 A and guide wire lumen 58 so that it advances distally of the distal end 51 of the catheter. Thus, guide wire distal end 41B is advanced into the main vessel so that it is distal of the side-branch vessel. Guide wire 56A, which until this point has remained within guide wire lumen 53A (see FIG. 8K), is advanced distally as depicted in FIG. 8L and advanced into the main vessel distally of the side-branch vessel. Guide wire 41A is then withdrawn proximally through guide wire lumen 58 until guide wire distal end 41B is able to exit guide wire lumen distal end 55B, as shown in FIG. 8L. Since guide wire lumen 55B is preformed and has bias, it will spring outwardly. Guide wire 41 A can then be advanced into the side-branch vessel for further positioning. As the catheter 50 is advanced over the guide wires, distal portion 4 IB of the guide wire will push against the ostium of the side-branch vessel thereby insuring the location of main- vessel stent 20, and importantly aperture 25 will align with the opening to the side-branch vessel 5.
In order to assist in properly aligning main-vessel stent 20 in main-vessel 6, positioning guide wire lumen 55 A, on main-vessel catheter 50, can be radi opaque, or have a radiopaque marker associated therewith so that it is visible under fluoroscopy . Thus, when advancing main-vessel catheter 50, the proper orientation can be more easily determined by viewing the position of positioning guide wire lumen 55 A in connection with main-vessel 6. Additionally, positioning guide wire 56A for positioning main- vessel stent 20 is either radiopaque or has radiopaque portions, such as gold markers, to assist in positioning and orienting the catheter and stent during implantation and deployment.
While the foregoing description contemplates implanting a stent in side- branch vessel 5 prior to implanting main-vessel stent 20 in main-vessel 6, in an alternative embodiment, the implanting procedure can be reversed. However, it should be understood that by implanting main-vessel stent 20 in main-vessel 6, and subsequently implanting a stent in side-branch vessel 5, aperture 25 must be carefully aligned with side-branch vessel 5 so that side-branch catheter 31 can be advanced through expanded main-vessel stent 20 and aperture 25 and into side-branch vessel 5 for implanting the stent in side-branch vessel 5. While main- vessel catheter 50 has been described herein as being of the rapid-exchange type, it also can be of a conventional over-the-wire-type catheter. In over- the- wire-type catheters, the guide wire lumen extends from the distal end of the catheter to the proximal end with no side port as is found in the rapid-exchange-type catheters. Typical of over-the-wire-type catheters is the type disclosed in U.S. Patent Nos.4,323 ,071 and B 1 4,323 ,071 , which are incorporated herein by reference, and are commonly assigned and commonly owned by Advanced Cardiovascular Systems, Inc., Santa Clara, California.
In another embodiment of the invention, as depicted in FIG. 10, main- vessel stent 20 may be mounted on a main- vessel catheter 100. In this embodiment, main- vessel catheter 100 includes an expandable portion 105 located near distal end 110 of main-vessel catheter 100. Main-vessel catheter 100 includes guide wire lumen 115 which extends to port 120 located at distal end 110 of the main- vessel catheter. Expandable portion 105 includes a proximal balloon 125 and a distal balloon 130 separated by exit notch 135. Exit notch 135 is formed from the body of main- vessel catheter 100, and may have the same, a lesser or a greater diameter than the remainder of the catheter body. The main- vessel catheter 100 also has a stent-positioning guide wire lumen 140 that extends through the main- vessel catheter to exit port 145 located in exit notch 135. Main- vessel catheter 100 may be configured as a so-called rapid- exchange catheter system which includes a slit (not shown) as is known in the art, and appropriate side ports for introduction of the guide wire and stent-positioning guide wire (not shown). Alternatively, main- vessel catheter 100 may be configured as an over-the-wire catheter system. Typically, proximal balloon 125 and distal balloon 130 are non-distensible balloons of the type known in the art for delivering and expanding stents.
Main- vessel stent 20 is mounted on expandable portion 105 of main- vessel catheter 100 by crimping stent 20 over proximal balloon 125 and distal balloon 130 and orienting stent 20 so that aperture 25 is positioned over exit port 145 in exit notch 135 of main- vessel catheter 100 to allow a stent-positioning guide wire to extend out of exit port 145, through aperture 25 and into the ostium of side-branch vessel 5. In one embodiment, exit notch 135 includes a marker band 150 to aid in positioning aperture 25 of main- vessel stent 20 in the desired location relative to the ostium of side- branch vessel 5.
The procedure for positioning and implanting main- vessel stent 20 using main- vessel catheter 100 is similar to the method described above with reference to FIGS. 8A-8C and 9A-9D. Expansion of stent 20, however, differs from the method described above since expandable portion 105 of main- vessel catheter 100 includes proximal balloon 125 and distal balloon 130 separated by exit notch 135. In this embodiment, after main-vessel stent 20 is located and properly situated at the site of the lesion in main- vessel 6 and the aperture 25 of main- vessel stent 20 is properly aligned with the ostium of side-branch vessel 5, proximal balloon 125 and distal balloon 130 are expanded either simultaneously or separately, depending on the physicians choice. After expansion, proximal balloon 125 and distal balloon 130 are deflated, and main- vessel catheter 100 is pulled back by the physician by pulling a portion of the catheter from the patient's body. Main- vessel catheter 100 is pulled back just sufficiently to position the distal balloon 130 in the center of stent 20 so that the portion of stent 20 originally positioned over exit notch 135 may be expanded. Once distal balloon 130 is properly positioned, it is expanded, thus completing the expansion of stent 20. Distal balloon 130 is then deflated, and main- vessel catheter 100 is withdrawn from the patient. As described previously, the design of main-catheter 100 allows both the main and stent-positioning guide wires to remain in the main- essel and side-branch vessels in case further stent deployment or expansion are necessary.
While the invention herein has been illustrated and described in terms of an apparatus and method for stenting bifurcated vessels, it will be apparent to those skilled in the art that the stents and delivery systems herein can be used in the coronary arteries, veins and other arteries throughout the patient's vascular system. Certain dimensions and materials of manufacture have been described herein, and can be modified without departing from the spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. A main- vessel stent for implanting in a main vessel adjacent a bifurcation, comprising: a cylindrical member having a distal end and a proximal end and an outer wall surface therebetween; and an aperture on the outer wall surface, the aperture having a perimeter formed entirely of closed stent cells, the aperture being sized and positioned on the outer wall surface so that when the stent is implanted in a main vessel, the aperture is aligned with a side-branch vessel thereby allowing substantially unrestricted blood flow from the main vessel through to the side-branch vessel.
2. The main- vessel stent of claim 1 , wherein the stent is expandable from a first smaller diameter for delivery in a body lumen to a second expanded diameter by plastically deforming the stent beyond the elastic limits of the material forming the stent.
3. The main- vessel stent of claim 1 , wherein the stent is formed from a self-expanding material so that the stent expands from a first smaller diameter for delivery through a body lumen to a second implanted diameter in the body lumen.
4. The main-vessel stent of claim 1 , wherein the cylindrical member further comprises: a distal region adjacent the distal end, a proximal region adjacent the proximal end and a central region located therebetween; and wherein the aperture is formed in the central region.
5. The main- vessel stent of claim 4, wherein the stent cells of the distal and proximal regions have a first cell size and the stent cells of the central region have a second cell size.
6. The main- vessel stent of claim 5, wherein the second cell size is less than the first cell size.
7. The main- vessel stent of claim 6, wherein the second cell size is about one half the size of the first cell size.
8. A stent delivery assembly for treating bifurcated vessels having a main vessel and a side-branch vessel, comprising: a catheter having a proximal end and distal end and an outer surface extending longitudinally therebetween; a first expandable member having a distal end and proximal end mounted on the catheter proximate to the distal end of the catheter; a second expandable member having a distal end and a proximal end mounted on the catheter proximate to the proximal end of the first expandable member; a tracking guide wire lumen extending within at least a porti on of the catheter; a tracking guide wire having a distal end and a proximal end and sized for slidable movement within the tracking guide wire lumen; a positioning guide wire lumen having a distal end and a proximal end and extending within at least a portion of the catheter and adapted to receive for slidable engagement a positioning guide wire, the positioning guide wire having a distal end and a proximal end, the distal end of the positioning guide wire lumen forming an exit port opening in the outer surface of the catheter between the first expandable member and the second expandable member.
9. The stent delivery assembly of claim 8, wherein a stent is mounted on the first and second expandable members.
10. The stent delivery assembly of claim 9, wherein the stent includes an aperture.
11. The stent delivery assembly of claim 10, wherein the stent is mounted on the first and second expandable members such that the aperture of the stent is aligned with the opening in the side wall of the catheter so that the positioning guide wire may be extended through the exit port opening and aperture.
12. The stent delivery assembly of claim 8, further comprising a marker band located adjacent the exit port opening.
13. The stent delivery assembly of claim 8, wherein the catheter is a rapid exchange catheter and includes a distal end opening in the tracking guide wire lumen and a side port opening on the outer surface of the catheter so that the tracking guide wire extends through the side port opening, through the tracking guide wire lumen, and out the distal end opening, and the catheter further includes a slit extending from the side port opening to just proximal of the second expandable member so that the tracking guide wire can be unzipped through the slit during catheter exchanges.
14. The stent delivery assembly of claim 8, wherein the catheter is an over-the-wire catheter and includes a distal end opening in the tracking guide wire lumen and a proximal opening in the tracking guide wire lumen so that the tracking guide wire extends from outside the proximal end opening, through the tracking guide wire lumen, and out the distal end opening.
15. A method of stenting a bifurcated vessel having a main vessel and a side-branch vessel, comprising: providing a catheter for delivering and implanting a main- vessel stent having an aperture bordered by closed stent cells; implanting the main-vessel stent in a main vessel of the bifurcation, the main-vessel stent spanning an opening to a side-branch vessel and precisely orienting the aperture of the main-vessel stent with respect to the side-branch ostium so that subsequent access to the side-branch vessel is not compromised; and withdrawing the catheter from the patient.
16. A method of implanting a stent in a main vessel adjacent to a bifurcation with a side-branch vessel, comprising: providing a catheter assembly having a tracking guide wire lumen extending through at least a portion thereof, an expandable member associated with the catheter and having a main- vessel stent having an aperture bordered by closed stent cells mounted thereon, a stent-positioning guide wire lumen, a tracking guide wire sized for slidable movement within the tracking guide wire lumen, and a stent- positioning guide wire sized for slidable movement within the stent-positioning guide wire lumen; advancing a distal end of the tracking guide wire into the main vessel and distal to a target area; advancing the catheter along the tracking guide wire in the main vessel to a position just adjacent of the side-branch vessel; advancing a distal end of the stent-positioning guide wire into the side-branch vessel; further advancing the catheter so that the distal end of the positioning guide wire anchors the catheter at the side-branch ostium; aligning the aperture of the main- vessel stent with the ostium of the side-branch vessel; inflating the expandable member thereby expanding and implanting the main- vessel stent at the target area in the main vessel; deflating the expandable member and withdrawing the catheter from the patient; and withdrawing the tracking and stent-positioning guide wires from the patient.
17. A method of implanting a stent in a main vessel adjacent to a bifurcation with a side-branch vessel, comprising: providing a catheter assembly having a tracking guide wire lumen extending through at least a portion thereof, an expandable section having a first expandable member and a second expandable member proximal to the first expandable member associated with the catheter and separated by an exit opening, and having a main- vessel stent having an aperture bordered by closed stent cells mounted on the expandable section, a stent-positioning guide wire lumen, a tracking guide wire sized for slidable movement within the tracking guide wire lumen, and a stent-positioning guide wire sized for slidable movement within the stent-positioning guide wire lumen; advancing a distal end of the tracking guide wire into the main vessel and distal to a target area; advancing the catheter along the tracking guide wire in the main vessel to a position adjacent the side-branch vessel; advancing a distal end of the stent-positioning guide wire through the opening and aperture into the side-branch vessel; further advancing the catheter so that the distal end of the positioning guide wire anchors the catheter at the side-branch ostium; aligning the aperture of the main-vessel stent with the ostium of the side-branch vessel; inflating the first and second expandable members thereby expanding and implanting the main-vessel stent at the target area in the main vessel; deflating the first and second expandable members; withdrawing positioning guide wire from the side-branch vessel back into the lumen of the catheter and withdrawing the catheter from the patient until the first expandable member is positioned beneath the aperture; inflating the first expandable member thereby completing the expanding and implanting of the stent in the target area of the main vessel; deflating the first expandable member and withdrawing the catheter from the patient; and withdrawing the tracking and stent-positioning guide wires from the patient.
PCT/US2001/032470 2000-11-14 2001-10-16 Stent and catheter assembly and method for treating bifurcated vessels WO2002039926A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002213349A AU2002213349A1 (en) 2000-11-14 2001-10-16 Stent and catheter assembly and method for treating bifurcated vessels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/713,648 US6582394B1 (en) 2000-11-14 2000-11-14 Stent and catheter assembly and method for treating bifurcated vessels
US09/713,648 2000-11-14

Publications (2)

Publication Number Publication Date
WO2002039926A2 true WO2002039926A2 (en) 2002-05-23
WO2002039926A3 WO2002039926A3 (en) 2002-08-15

Family

ID=24866937

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/032470 WO2002039926A2 (en) 2000-11-14 2001-10-16 Stent and catheter assembly and method for treating bifurcated vessels

Country Status (3)

Country Link
US (1) US6582394B1 (en)
AU (1) AU2002213349A1 (en)
WO (1) WO2002039926A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009202301B1 (en) * 2009-06-10 2009-07-30 Cook Incorporated Reinforcing ring
US7758634B2 (en) 2001-02-26 2010-07-20 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US7799064B2 (en) 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8070729B2 (en) 2006-05-11 2011-12-06 YMED, Inc. Systems and methods for treating a vessel using focused force
WO2013034983A1 (en) * 2011-09-06 2013-03-14 E. V. R. Endovascular Researches S.A. Microcatheter
US8486025B2 (en) 2006-05-11 2013-07-16 Ronald J. Solar Systems and methods for treating a vessel using focused force
US9050437B2 (en) 2004-03-04 2015-06-09 YMED, Inc. Positioning device for ostial lesions
US9504473B2 (en) 2004-03-04 2016-11-29 Y Med Inc. Vessel treatment devices
NL2020410B1 (en) * 2018-02-09 2019-08-19 Univ Erasmus Med Ct Rotterdam Stent delivery system
US11744723B2 (en) 2004-03-04 2023-09-05 Y Med, Inc. Vessel treatment devices

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6099497A (en) 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US8257425B2 (en) 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
JP2003525065A (en) * 1999-01-27 2003-08-26 ボストン サイエンティフィック リミテッド Bifurcation stent delivery system
EP1258230A3 (en) 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US8080048B2 (en) * 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US20030135266A1 (en) * 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7309350B2 (en) * 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7270668B2 (en) * 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US7351255B2 (en) * 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7300459B2 (en) * 2002-10-17 2007-11-27 Heuser Richard R Stent with covering and differential dilation
US9125733B2 (en) * 2003-01-14 2015-09-08 The Cleveland Clinic Foundation Branched vessel endoluminal device
CA2512610C (en) * 2003-01-14 2008-12-23 The Cleveland Clinic Foundation Branched vessel endoluminal device
US7166088B2 (en) * 2003-01-27 2007-01-23 Heuser Richard R Catheter introducer system
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7972372B2 (en) 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7731747B2 (en) 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US7717953B2 (en) 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US6840569B1 (en) * 2003-07-22 2005-01-11 Arthur Donald Leigh Caravan
US7604621B2 (en) * 2003-07-30 2009-10-20 Boston Scientific Scimed, Inc. Bifurcated stent delivery system
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7402141B2 (en) * 2003-08-27 2008-07-22 Heuser Richard R Catheter guidewire system using concentric wires
US7192440B2 (en) * 2003-10-15 2007-03-20 Xtent, Inc. Implantable stent delivery devices and methods
US9078780B2 (en) * 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US20080228146A1 (en) * 2007-03-13 2008-09-18 Yoav Shaked Positioning device for ostial lesions
US7753951B2 (en) * 2004-03-04 2010-07-13 Y Med, Inc. Vessel treatment devices
US8007528B2 (en) 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
US7449027B2 (en) * 2004-03-29 2008-11-11 Cook Incorporated Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US9358141B2 (en) 2004-03-31 2016-06-07 Cook Medical Technologies Llc Stent deployment device
US8048140B2 (en) * 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
JP5054524B2 (en) 2004-06-08 2012-10-24 アドバンスド ステント テクノロジーズ, インコーポレイテッド Stent with protruding branch for branch pipe
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US20090012429A1 (en) * 2004-08-25 2009-01-08 Heuser Richard R Catheter guidewire system using concentric wires
US8545418B2 (en) 2004-08-25 2013-10-01 Richard R. Heuser Systems and methods for ablation of occlusions within blood vessels
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
WO2006113501A1 (en) 2005-04-13 2006-10-26 The Cleveland Clinic Foundation Endoluminal prosthesis
US8317855B2 (en) 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
US8480728B2 (en) 2005-05-26 2013-07-09 Boston Scientific Scimed, Inc. Stent side branch deployment initiation geometry
US7320702B2 (en) 2005-06-08 2008-01-22 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses (III)
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US7833259B2 (en) * 2005-07-25 2010-11-16 Cook Incorporated Fenestrated endoluminal stent system
US9233012B2 (en) 2005-09-07 2016-01-12 RBKPark, LLC Medical stent
US7632304B2 (en) * 2005-09-07 2009-12-15 Rbkpark Llc Coronary stent
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US7731741B2 (en) * 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US8038706B2 (en) 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US20070112418A1 (en) 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US20070142904A1 (en) * 2005-12-20 2007-06-21 Boston Scientific Scimed, Inc. Bifurcated stent with multiple locations for side branch access
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
US8062321B2 (en) 2006-01-25 2011-11-22 Pq Bypass, Inc. Catheter system for connecting adjacent blood vessels
US8821561B2 (en) 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US20070208414A1 (en) * 2006-03-06 2007-09-06 Shawn Sorenson Tapered strength rings on a bifurcated stent petal
US7833264B2 (en) 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US8298278B2 (en) 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8348991B2 (en) * 2006-03-29 2013-01-08 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US8043358B2 (en) * 2006-03-29 2011-10-25 Boston Scientific Scimed, Inc. Stent with overlap and high extension
US9707113B2 (en) * 2006-04-19 2017-07-18 Cook Medical Technologies Llc Twin bifurcated stent graft
US7744643B2 (en) 2006-05-04 2010-06-29 Boston Scientific Scimed, Inc. Displaceable stent side branch structure
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
US20080269865A1 (en) * 2006-08-07 2008-10-30 Xtent, Inc. Custom Length Stent Apparatus
US8246670B2 (en) 2006-08-23 2012-08-21 Abbott Cardiovascular Systems Inc. Catheter system and method for delivering medical devices
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
US20080114444A1 (en) * 2006-11-09 2008-05-15 Chun Ho Yu Modular stent graft and delivery system
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US7959668B2 (en) 2007-01-16 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8118861B2 (en) 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8647376B2 (en) 2007-03-30 2014-02-11 Boston Scientific Scimed, Inc. Balloon fold design for deployment of bifurcated stent petal architecture
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US9440058B2 (en) * 2007-12-17 2016-09-13 Cook Medical Technologies, LLC Device for enabling repeated access to a vessel
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US8002816B2 (en) * 2007-12-21 2011-08-23 Cleveland Clinic Foundation Prosthesis for implantation in aorta and method of using same
EP2242456A2 (en) 2007-12-31 2010-10-27 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
WO2009149405A1 (en) 2008-06-05 2009-12-10 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
JP5662310B2 (en) 2008-06-05 2015-01-28 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Shrinkable branch device and method of manufacturing the same
WO2010002931A1 (en) 2008-07-01 2010-01-07 Endologix, Inc. Catheter system
US8945198B2 (en) * 2008-07-31 2015-02-03 Boston Scientific Scimed, Inc. Locating side catheter branch relative to inflation portion
US8900207B2 (en) * 2008-08-29 2014-12-02 Barry F. Uretsky Apparatus and method for treatment of bifurcation lesions
CA2739007C (en) 2008-09-25 2017-10-31 Advanced Bifurcation Systems Inc. Partially crimped stent
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US8979917B2 (en) 2008-09-25 2015-03-17 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
US20110054586A1 (en) 2009-04-28 2011-03-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US20100318170A1 (en) * 2009-06-15 2010-12-16 Richard Newhauser Proximal catheter flap for managing wire twist
US8382818B2 (en) 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
EP2506776A4 (en) * 2009-12-02 2015-03-18 Apica Cardiovascular Ireland Ltd Device system and method for tissue access site closure
WO2011109067A1 (en) * 2010-02-18 2011-09-09 Suhr William S Side branch accessible balloon for bifurcation stenting
US8512393B2 (en) 2010-02-26 2013-08-20 ProMed, Inc. Apparatus for vessel access closure
AU2011232360B2 (en) 2010-03-24 2015-10-08 Advanced Bifurcation Systems Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
WO2011119883A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US8920486B2 (en) 2010-05-18 2014-12-30 RBKPark, LLC Medical device
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
US9707108B2 (en) 2010-11-24 2017-07-18 Tryton Medical, Inc. Support for treating vascular bifurcations
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
EP2672925B1 (en) 2011-02-08 2017-05-03 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations
US8808350B2 (en) 2011-03-01 2014-08-19 Endologix, Inc. Catheter system and methods of using same
WO2013162724A1 (en) 2012-04-26 2013-10-31 Tryton Medical, Inc. Support for treating vascular bifurcations
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
CN109803607B (en) * 2016-06-13 2021-07-20 主动脉公司 Systems, devices, and methods for marking and/or enhancing fenestrations in prosthetic implants
CN109966019B (en) * 2017-12-27 2021-06-04 先健科技(深圳)有限公司 Covered stent
WO2021252529A1 (en) * 2020-06-09 2021-12-16 Thru-Flo Endovascular, Inc. Methods of manufacturing a y-shaped branch point flow diversion device and methods of deploying a y-shaped branch point flow diversion system
JP2023529720A (en) 2020-06-09 2023-07-11 スルーフロー エンドバスキュラー インコーポレイテッド Manufacturing method of Y-shaped branch point flow dividing device and deployment method of Y-shaped branch point flow dividing system

Family Cites Families (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2845959A (en) 1956-03-26 1958-08-05 John B Sidebotham Bifurcated textile tubes and method of weaving the same
US2990605A (en) 1957-01-30 1961-07-04 Demsyk Paul Method of forming artificial vascular members
US2978787A (en) 1957-04-18 1961-04-11 Meadox Medicals Inc Synthetic vascular implants and the manufacture thereof
US3096560A (en) 1958-11-21 1963-07-09 William J Liebig Process for synthetic vascular implants
US3142067A (en) 1958-11-21 1964-07-28 William J Liebig Synthetic vascular implants
US3029819A (en) 1959-07-30 1962-04-17 J L Mcatee Artery graft and method of producing artery grafts
US3397699A (en) 1966-05-05 1968-08-20 Gerald C. Kohl Retaining catheter having resiliently biased wing flanges
US3945052A (en) 1972-05-01 1976-03-23 Meadox Medicals, Inc. Synthetic vascular graft and method for manufacturing the same
CH557672A (en) 1973-07-04 1975-01-15 Vnii Khirurgicheskoi Apparatur SURGICAL DEVICE WITH MEANS FOR REPLACING VOLLUS ORGANS.
US4061134A (en) 1975-10-28 1977-12-06 Samuels Peter B Arterial graft device
US4047252A (en) 1976-01-29 1977-09-13 Meadox Medicals, Inc. Double-velour synthetic vascular graft
US4041931A (en) 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
US4140126A (en) 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4193137A (en) 1977-05-06 1980-03-18 Meadox Medicals, Inc. Warp-knitted double-velour prosthesis
US4202349A (en) 1978-04-24 1980-05-13 Jones James W Radiopaque vessel markers
US4214587A (en) 1979-02-12 1980-07-29 Sakura Chester Y Jr Anastomosis device and method
US4517687A (en) 1982-09-15 1985-05-21 Meadox Medicals, Inc. Synthetic woven double-velour graft
US4560374A (en) 1983-10-17 1985-12-24 Hammerslag Julius G Method for repairing stenotic vessels
US5104399A (en) 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4787899A (en) 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US5108424A (en) 1984-01-30 1992-04-28 Meadox Medicals, Inc. Collagen-impregnated dacron graft
US5197977A (en) 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4562596A (en) 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
SU1217402A1 (en) 1984-05-22 1986-03-15 Харьковский научно-исследовательский институт общей и неотложной хирургии Blood vessel prosthesis
SU1318235A1 (en) 1984-07-10 1987-06-23 Харьковский научно-исследовательский институт общей и неотложной хирургии Arrangement for fitting a prosthesis into a blood vessel
US4728328A (en) 1984-10-19 1988-03-01 Research Corporation Cuffed tubular organic prostheses
US4577631A (en) 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
ES8705239A1 (en) 1984-12-05 1987-05-01 Medinvent Sa A device for implantation and a method of implantation in a vessel using such device.
US4652263A (en) 1985-06-20 1987-03-24 Atrium Medical Corporation Elasticization of microporous woven tubes
US4693249A (en) 1986-01-10 1987-09-15 Schenck Robert R Anastomosis device and method
US4878906A (en) 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
US5350395A (en) 1986-04-15 1994-09-27 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
SU1482714A2 (en) 1986-10-15 1989-05-30 Харьковский научно-исследовательский институт общей и неотложной хирургии Device for setting prosthesis into blood vessel
US4793348A (en) 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
SU1389778A2 (en) 1986-11-26 1988-04-23 Харьковский научно-исследовательский институт общей и неотложной хирургии Arrangement for fitting a prosthesis into blood vessel
IT1202558B (en) 1987-02-17 1989-02-09 Alberto Arpesani INTERNAL PROSTHESIS FOR THE REPLACEMENT OF A PART OF THE HUMAN BODY PARTICULARLY IN THE VASCULAR OPERATIONS
SU1457921A1 (en) 1987-03-10 1989-02-15 Харьковский научно-исследовательский институт общей и неотложной хирургии Self-fixing prosthesis of blood vessel
US4795465A (en) 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
US4795458A (en) 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4892539A (en) 1988-02-08 1990-01-09 D-R Medical Systems, Inc. Vascular graft
US4830003A (en) 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5226913A (en) 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
US5127919A (en) 1988-12-14 1992-07-07 Vascutec Corporation Woven vascular graft
US4969896A (en) 1989-02-01 1990-11-13 Interpore International Vascular graft prosthesis and method of making the same
US5178634A (en) 1989-03-31 1993-01-12 Wilson Ramos Martinez Aortic valved tubes for human implants
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
DE9010130U1 (en) 1989-07-13 1990-09-13 American Medical Systems, Inc., Minnetonka, Minn., Us
US5360443A (en) 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5578071A (en) 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
EP0461791B1 (en) 1990-06-11 1997-01-02 Hector D. Barone Aortic graft and apparatus for repairing an abdominal aortic aneurysm
US5156619A (en) 1990-06-15 1992-10-20 Ehrenfeld William K Flanged end-to-side vascular graft
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5178630A (en) 1990-08-28 1993-01-12 Meadox Medicals, Inc. Ravel-resistant, self-supporting woven graft
ATE121303T1 (en) 1990-10-04 1995-05-15 Schneider Europ Ag BALLOON DILATION CATHETER.
US5222971A (en) 1990-10-09 1993-06-29 Scimed Life Systems, Inc. Temporary stent and methods for use and manufacture
FR2673843B1 (en) 1991-03-14 1995-01-13 Centre Nat Rech Scient IMPLANTABLE, BIORESORBABLE PHARMACEUTICAL COMPOSITION BASED ON POLY (LACTIC ACID), INTENDED TO IMPLEMENT A LOCAL INTERNAL ANTIBOTHERAPY.
US5628783A (en) 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5743875A (en) 1991-05-15 1998-04-28 Advanced Cardiovascular Systems, Inc. Catheter shaft with an oblong transverse cross-section
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
US5197976A (en) 1991-09-16 1993-03-30 Atrium Medical Corporation Manually separable multi-lumen vascular graft
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5234457A (en) 1991-10-09 1993-08-10 Boston Scientific Corporation Impregnated stent
AU669338B2 (en) 1991-10-25 1996-06-06 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5693084A (en) 1991-10-25 1997-12-02 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5720776A (en) 1991-10-25 1998-02-24 Cook Incorporated Barb and expandable transluminal graft prosthesis for repair of aneurysm
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
US5316023A (en) 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
WO1995009585A1 (en) 1993-10-01 1995-04-13 Imperial College Of Science, Technology & Medicine Vascular prostheses
US5639278A (en) 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5632772A (en) 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
AU1091095A (en) 1993-11-08 1995-05-29 Harrison M. Lazarus Intraluminal vascular graft and method
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
US5607444A (en) 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
DE9319267U1 (en) 1993-12-15 1994-02-24 Vorwerk Dierk Dr Aortic endoprosthesis
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5507769A (en) 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5629077A (en) * 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
US5857998A (en) 1994-06-30 1999-01-12 Boston Scientific Corporation Stent and therapeutic delivery system
US5575817A (en) 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US5609605A (en) 1994-08-25 1997-03-11 Ethicon, Inc. Combination arterial stent
US5527355A (en) 1994-09-02 1996-06-18 Ahn; Sam S. Apparatus and method for performing aneurysm repair
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
JP2911763B2 (en) 1994-10-27 1999-06-23 三桜子 布川 Artificial blood vessel
USD376011S (en) 1994-10-27 1996-11-26 Mioko Nunokawa Synthetic vascular prosthesis
CA2134997C (en) 1994-11-03 2009-06-02 Ian M. Penn Stent
US5613980A (en) 1994-12-22 1997-03-25 Chauhan; Tusharsindhu C. Bifurcated catheter system and method
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US5683449A (en) 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
EP0813397A4 (en) 1995-03-10 1999-10-06 Cardiovascular Concepts Inc Tubular endoluminar prosthesis having oblique ends
US5709713A (en) 1995-03-31 1998-01-20 Cardiovascular Concepts, Inc. Radially expansible vascular prosthesis having reversible and other locking structures
IL122202A0 (en) 1995-06-08 1998-04-05 Bard Galway Ltd Bifurcated endovascular stent
FR2737969B1 (en) 1995-08-24 1998-01-30 Rieu Regis INTRALUMINAL ENDOPROSTHESIS IN PARTICULAR FOR ANGIOPLASTY
US5669924A (en) 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
FR2740346A1 (en) 1995-10-30 1997-04-30 Debiotech Sa ANGIOPLASTY DEVICE FOR ARTERIAL BIFURCATION
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
WO1997025937A1 (en) * 1996-01-18 1997-07-24 Jang G David Programmable variably flexible modular stents
US5713949A (en) 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
WO1997045073A1 (en) 1996-05-31 1997-12-04 Bard Galway Limited Bifurcated endovascular stents and method and apparatus for their placement
US5617878A (en) 1996-05-31 1997-04-08 Taheri; Syde A. Stent and method for treatment of aortic occlusive disease
US5676697A (en) 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5749825A (en) 1996-09-18 1998-05-12 Isostent, Inc. Means method for treatment of stenosed arterial bifurcations
US5755778A (en) 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
AU4896797A (en) * 1996-11-04 1998-05-29 Davidson, Charles Extendible stent apparatus and method for deploying the same
US5972017A (en) 1997-04-23 1999-10-26 Vascular Science Inc. Method of installing tubular medical graft connectors
JP4042998B2 (en) 1997-01-29 2008-02-06 クック インコーポレイテッド Bell bottom modular stent graft
US5720735A (en) 1997-02-12 1998-02-24 Dorros; Gerald Bifurcated endovascular catheter
US6096073A (en) 1997-02-25 2000-08-01 Scimed Life Systems, Inc. Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US6096071A (en) * 1998-03-26 2000-08-01 Yadav; Jay S. Ostial stent
DE29708803U1 (en) 1997-05-17 1997-07-31 Jomed Implantate Gmbh Radially expandable stent for implantation in a body vessel in the area of a vascular branch
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
US6165195A (en) 1997-08-13 2000-12-26 Advanced Cardiovascylar Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6001124A (en) 1997-10-09 1999-12-14 Vascular Science, Inc. Oblique-angle graft connectors
US5893887A (en) 1997-10-14 1999-04-13 Iowa-India Investments Company Limited Stent for positioning at junction of bifurcated blood vessel and method of making
US6033435A (en) 1997-11-03 2000-03-07 Divysio Solutions Ulc Bifurcated stent and method for the manufacture and delivery of same
US6030414A (en) 1997-11-13 2000-02-29 Taheri; Syde A. Variable stent and method for treatment of arterial disease
US6099597A (en) 1997-12-17 2000-08-08 Advanced Micro Devices, Inc. Picker nest for holding an IC package with minimized stress on an IC component during testing
US6099497A (en) * 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US6129738A (en) 1998-06-20 2000-10-10 Medtronic Ave, Inc. Method and apparatus for treating stenoses at bifurcated regions
US6117117A (en) 1998-08-24 2000-09-12 Advanced Cardiovascular Systems, Inc. Bifurcated catheter assembly
US6293967B1 (en) * 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US5976155A (en) 1999-03-05 1999-11-02 Advanced Cardiovascular Systems, Inc. System for removably securing a stent on a catheter assembly and method of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758634B2 (en) 2001-02-26 2010-07-20 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US7799064B2 (en) 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US9504473B2 (en) 2004-03-04 2016-11-29 Y Med Inc. Vessel treatment devices
US9050437B2 (en) 2004-03-04 2015-06-09 YMED, Inc. Positioning device for ostial lesions
US11744723B2 (en) 2004-03-04 2023-09-05 Y Med, Inc. Vessel treatment devices
US8070729B2 (en) 2006-05-11 2011-12-06 YMED, Inc. Systems and methods for treating a vessel using focused force
US8262621B2 (en) 2006-05-11 2012-09-11 YMED, Inc. Systems and methods for treating a vessel using focused force
US8486025B2 (en) 2006-05-11 2013-07-16 Ronald J. Solar Systems and methods for treating a vessel using focused force
AU2009202301B8 (en) * 2009-06-10 2009-12-03 Cook Incorporated Reinforcing ring
AU2009202301B1 (en) * 2009-06-10 2009-07-30 Cook Incorporated Reinforcing ring
US9918823B2 (en) 2009-06-10 2018-03-20 Cook Medical Technologies Llc Reinforcing ring
WO2013034983A1 (en) * 2011-09-06 2013-03-14 E. V. R. Endovascular Researches S.A. Microcatheter
NL2020410B1 (en) * 2018-02-09 2019-08-19 Univ Erasmus Med Ct Rotterdam Stent delivery system

Also Published As

Publication number Publication date
US6582394B1 (en) 2003-06-24
AU2002213349A1 (en) 2002-05-27
WO2002039926A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
US6582394B1 (en) Stent and catheter assembly and method for treating bifurcated vessels
US6387120B2 (en) Stent and catheter assembly and method for treating bifurcations
US6508836B2 (en) Stent and catheter assembly and method for treating bifurcations
US6264682B1 (en) Stent and catheter assembly and method for treating bifurcations
US6383213B2 (en) Stent and catheter assembly and method for treating bifurcations
US6221090B1 (en) Stent delivery assembly
US6361555B1 (en) Stent and stent delivery assembly and method of use
US7955379B2 (en) Stent and catheter assembly and method for treating bifurcations
AU1956201A (en) Catheter assembly for delivering stents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP